Tajuk
ENTRECTINIB for Neurotrophic Tropomyosin Receptor Kinase (NTRK) Fusion-Positive, Locally Advanced Or Metastatic Solid Tumours_ And Metastatic, ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)
Tahun
2019-014-S
Lampiran-lampiran
2019-014-S ENTRECTINIB for Neurotrophic Tropomyosin Receptor Kinase (NTRK) Fusion-Positive, Locally Advanced Or Metastatic Solid Tumours_ And Metastatic, ROS1-Positive Non-Small Cell Lung Cancer (NSCLC).pdf